Free Trial

CannaPharmaRX Q4 2022 Earnings Report

CannaPharmaRX logo
$0.0078 0.00 (-13.33%)
(As of 12/20/2024 05:55 PM ET)

CannaPharmaRX Earnings Headlines

PSIQ Profile Solutions, Inc.
This is the worst sign for the U.S. stock market in 50 years
The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"
CannaPharmaRX, Inc. (CPMD)
CannaPharmaRx to Host Investor Conference Call
See More CannaPharmaRX Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CannaPharmaRX? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CannaPharmaRX and other key companies, straight to your email.

About CannaPharmaRX

CannaPharmaRX (OTCMKTS:CPMD) operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

View CannaPharmaRX Profile

More Earnings Resources from MarketBeat

Upcoming Earnings